Valuation: Cipla Limited

Market Cap 1,143B 11.85B 10.38B 9.64B 8.86B 16.69B 16.93B 115B 44.93B 559B 44.47B 43.51B 1,932B P/E 2027 *
27.2x
P/E 2028 * 22.2x
Enterprise Value 1,044B 10.82B 9.48B 8.8B 8.09B 15.24B 15.47B 105B 41.05B 511B 40.63B 39.76B 1,765B EV / Sales 2027 *
3.36x
EV / Sales 2028 * 2.94x
Free-Float
68.88%
Yield 2027 *
0.87%
Yield 2028 * 0.98%
1 day-1.21%
1 week-1.60%
Current month-3.43%
1 month+4.68%
3 months+14.82%
6 months+3.32%
Current year-6.37%
1 week 1,395.7
Extreme 1395.7
1,466.6
1 month 1,395.7
Extreme 1395.7
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,038
Extreme 1038
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2022-08-15
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-1.60%-3.99%+34.91% 12.02B
-0.96%+0.02%+14.81%+77.10% 48.88B
-0.99%-0.27%+66.69%+108.95% 35.72B
-1.47%-0.64%+16.11%+83.68% 11.84B
+0.47%+0.94%+34.42%+136.73% 8.95B
+0.33%-1.13%+50.36%-5.96% 6.91B
-0.34%-2.25%+14.42%+31.69% 6.78B
-1.88%-4.56%+0.69%+192.09% 6.57B
-2.47%-5.28%-33.67%+6.76% 5.81B
-3.26%+1.47%+24.55%+145.02% 4.64B
Average -1.18%-1.51%+18.44%+81.10% 14.81B
Weighted average by Cap. -1.03%-0.20%+26.51%+84.00%

Financials

2027 *2028 *
Net sales 311B 3.22B 2.82B 2.62B 2.41B 4.53B 4.6B 31.2B 12.21B 152B 12.09B 11.83B 525B 347B 3.59B 3.15B 2.92B 2.69B 5.06B 5.13B 34.81B 13.63B 170B 13.49B 13.2B 586B
Net income 42.01B 435M 381M 354M 325M 613M 622M 4.22B 1.65B 20.56B 1.63B 1.6B 71.01B 51.55B 534M 468M 435M 399M 752M 764M 5.18B 2.03B 25.23B 2.01B 1.96B 87.14B
Net Debt -98.75B -1.02B -897M -832M -765M -1.44B -1.46B -9.92B -3.88B -48.32B -3.84B -3.76B -167B -125B -1.3B -1.14B -1.05B -969M -1.83B -1.85B -12.56B -4.91B -61.18B -4.86B -4.76B -211B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-07-22 1,415.10 -1.21% 1,722,239
26-07-21 ₹1,432.50 -0.63% 1,341,452
26-07-20 ₹1,441.60 +1.61% 1,494,196
26-07-17 ₹1,418.70 -0.76% 607,055
26-07-16 ₹1,429.50 -0.59% 568,731
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,415.10INR
Average target price
1,480.65INR
Spread / Average Target
+4.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock